How it works: Biologics block immune cells that are involved in psoriasis. These drugs are given by a shot or by an IV infusion. Side effects can include swelling or rash from the shot ...

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

The study revealed the following findings: 36.3% of psoriasis patients had elevated high-sensitivity C-reactive protein ...

Conventional systemic therapies used for psoriasis treatment include acitretin ... Patients weighing more than 100 kg are given 90-mg injections every 12 weeks. In 67% to 81% of patients who ...

The programme comprises two Phase III trials, ONWARD1 and ONWARD2, and an optional long-term extension trial, ONWARD3.

Humira is only given as an injection under the skin ... Watch this video to learn the right way to apply topical psoriasis medication, as well as more do's and don'ts.

For treatment of plaque psoriasis in adults ... The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate ...

A new clinical review explores the complexities of treating psoriasis during pregnancy and lactation highlighting limited ...

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...

Treatment with guselkumab among patients with psoriasis does not contribute to the risk for or progression of liver fibrosis.

Those who conducted phototherapy at home were provided with machines, taught how to use them, and given specific ... to adverse side effects. "Medications to treat psoriasis have a risk of side ...